Joint detection of important biomarkers and optimal dose-response model using penalties.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Works matching IS 02776715 AND DT 2007 AND VI 26 AND IP 27
Results: 16
1
2
Randomization with a posteriori constraints: Description and properties.
- Published in:
- Statistics in Medicine, 2007, v. 26, n. 27, p. 5033, doi. 10.1002/sim.2953
- By:
- Publication type:
- Article
3
Bayesian predictive power for interim adaptation in seamless phase II/III trials where the endpoint is survival up to some specified timepoint.
- Published in:
- Statistics in Medicine, 2007, v. 26, n. 27, p. 4925, doi. 10.1002/sim.2957
- By:
- Publication type:
- Article
4
A composite design for transition from a preliminary to a full-scale study.
- Published in:
- Statistics in Medicine, 2007, v. 26, n. 27, p. 5014, doi. 10.1002/sim.2963
- By:
- Publication type:
- Article
5
Modelling, prediction and adaptive adjustment of recruitment in multicentre trials.
- Published in:
- Statistics in Medicine, 2007, v. 26, n. 27, p. 4958, doi. 10.1002/sim.2956
- By:
- Publication type:
- Article
6
Sperm count as a surrogate endpoint for male fertility control.
- Published in:
- Statistics in Medicine, 2007, v. 26, n. 27, p. 4905, doi. 10.1002/sim.2967
- By:
- Publication type:
- Article
7
Implementing a decision-theoretic design in clinical trials: Why and how?
- Published in:
- Statistics in Medicine, 2007, v. 26, n. 27, p. 4939, doi. 10.1002/sim.2949
- By:
- Publication type:
- Article
8
A Bayesian approach for incorporating economic factors in sample size design for clinical trials of individual drugs and portfolios of drugs.
- Published in:
- Statistics in Medicine, 2007, v. 26, n. 27, p. 4976, doi. 10.1002/sim.2955
- By:
- Publication type:
- Article
9
Flexible two-stage design with sample size reassessment for survival trials.
- Published in:
- Statistics in Medicine, 2007, v. 26, n. 27, p. 5002, doi. 10.1002/sim.2966
- By:
- Publication type:
- Article
10
Sequential analysis of latent variables using mixed-effect latent variable models: Impact of non-informative and informative missing data.
- Published in:
- Statistics in Medicine, 2007, v. 26, n. 27, p. 4889, doi. 10.1002/sim.2959
- By:
- Publication type:
- Article
11
The SAEM algorithm for group comparison tests in longitudinal data analysis based on non-linear mixed-effects model.
- Published in:
- Statistics in Medicine, 2007, v. 26, n. 27, p. 4860, doi. 10.1002/sim.2950
- By:
- Publication type:
- Article
12
Global effects estimation for multidimensional outcomes.
- Published in:
- Statistics in Medicine, 2007, v. 26, n. 27, p. 4845, doi. 10.1002/sim.2983
- By:
- Publication type:
- Article
13
Modelling to extract more information from clinical trials data: On some roles for the bootstrap.
- Published in:
- 2007
- By:
- Publication type:
- journal article
14
French Society of Statistics, Biopharmacy and Health Group Fifth International Meeting on Statistical Methods in Biopharmacy ' Statistical Innovations in Clinical Trials' Opening remarks.
- Published in:
- Statistics in Medicine, 2007, v. 26, n. 27, p. 4843, doi. 10.1002/sim.2947
- By:
- Publication type:
- Article
15
Bayesian sample size determination in non-sequential clinical trials: Statistical aspects and some regulatory considerations.
- Published in:
- Statistics in Medicine, 2007, v. 26, n. 27, p. 4914, doi. 10.1002/sim.2958
- By:
- Publication type:
- Article
16
Correction.
- Published in:
- Statistics in Medicine, 2007, v. 26, n. 27, p. 5046, doi. 10.1002/sim.3084
- By:
- Publication type:
- Article